Background
ADHD diagnosis and treatment are shaped not only by clinical factors but also by cultural beliefs, social norms, and the wider community context. Families from minority ethnic and socially marginalised backgrounds often face additional barriers to engaging with ADHD medication, including stigma, distrust of services, concerns about over-medicalisation, and culturally rooted explanatory models of behaviour. Despite policy emphasis on personalised and equitable care, little is known about how these cultural and social influences interact with clinical decision-making processes, or how they contribute to observed disparities in ADHD medication uptake and adherence. Understanding these influences is essential for designing culturally responsive approaches that support informed choice and reduce inequalities in ADHD care.
Aims
This PhD project aims to explore how cultural identity, family beliefs, community narratives, and social experiences shape decisions about ADHD medication across ethnic minority communities in England.
Methods
A mixed-methods design will be used. Qualitative interviews with parents, young people, clinicians, and community stakeholders will provide in-depth insight into the lived experience of medication decision-making. Focus groups within community settings will explore shared narratives and collective influences on treatment choices. Survey-based methods or choice experiments may be incorporated to quantify preferences and examine variability across groups. Findings will be integrated using a rigorous triangulation approach.
Significance
The project’s significance lies in its potential to address persistent inequities in ADHD treatment. By understanding how cultural and social contexts shape medication decisions, the research will inform practical, evidence-based strategies to support diverse families, enhance trust and communication, and guide clinicians toward more culturally informed, equitable ADHD care pathways.
Primary Supervisor’s key papers in this area:
• Khan MU*, Hasan SS. Socioeconomic status and prescribing of ADHD medications: a study of ICB-level data in England. BMJ Mental Health. 2025 Mar 11;28(1).
• Khan MU*, Hasan SS. Phase-specific strategies and interventions to enhance medication adherence across different phases in ADHD: a systematic review and meta-analysis. Expert Review of Neurotherapeutics. 2024 Jun 9:1-2.
• Khan MU*, Balbontin C, Bliemer M, Aslani P. Using discrete choice experiment to investigate patients’ and parents’ preferences for initiating ADHD medication. Journal of Mental Health. 2023 Mar 4;32(2):373-85.
• Khan MU*, Balbontin C, Bliemer MC, Aslani P. Eliciting preferences for continuing medication among adult patients and parents of children with attention‐deficit hyperactivity disorder. Health Expectations. 2022 Jun;25(3):1094-107.
• Hasan SS, Bal N, Baker I, Kow CS, Khan MU. Adverse drug reaction reporting and prescribing trends of drugs for attention deficit hyperactivity disorder in primary care England, 2010–2019. Journal of attention disorders. 2022 Feb;26(3):467-75.
• Khan MU*, Aslani P. Exploring factors influencing initiation, implementation and discontinuation of medications in adults with ADHD. Health Expectations. 2021 May;24:82-94.